ClearPoint Neuro (CLPT) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart Transcripts

ClearPoint Neuro Revenue Highlights

Latest Revenue (Y)

$31.39M

Latest Revenue (Q)

$8.12M

Main Segment (Y)

Biologics and Drug Delivery Revenue

ClearPoint Neuro Revenue by Period

ClearPoint Neuro Revenue by Year

Date	Revenue	Change
2024-12-31	$31.39M	31.04%
2023-12-31	$23.95M	16.56%
2022-12-31	$20.55M	26.09%
2021-12-31	$16.30M	27.05%
2020-12-31	$12.83M	14.37%
2019-12-31	$11.22M	52.54%
2018-12-31	$7.35M	-0.36%
2017-12-31	$7.38M	28.35%
2016-12-31	$5.75M	25.15%
2015-12-31	$4.59M	27.46%
2014-12-31	$3.60M	-8.30%
2013-12-31	$3.93M	-22.29%
2012-12-31	$5.06M	32.48%
2011-12-31	$3.82M	43.03%
2010-12-31	$2.67M	-

ClearPoint Neuro generated $31.39M in revenue during NA 2024, up 31.04% compared to the previous quarter, and up 279.84% compared to the same period a year ago.

ClearPoint Neuro Revenue by Quarter

Date	Revenue	Change
2024-09-30	$8.12M	3.36%
2024-06-30	$7.86M	2.87%
2024-03-31	$7.64M	12.17%
2023-12-31	$6.81M	18.19%
2023-09-30	$5.76M	-3.16%
2023-06-30	$5.95M	9.52%
2023-03-31	$5.43M	5.01%
2022-12-31	$5.17M	0.54%
2022-09-30	$5.15M	-1.04%
2022-06-30	$5.20M	3.36%
2022-03-31	$5.03M	17.49%
2021-12-31	$4.28M	-6.38%
2021-09-30	$4.57M	34.02%
2021-06-30	$3.41M	-15.31%
2021-03-31	$4.03M	8.45%
2020-12-31	$3.72M	5.59%
2020-09-30	$3.52M	42.03%
2020-06-30	$2.48M	-20.47%
2020-03-31	$3.12M	-2.96%
2019-12-31	$3.21M	9.67%
2019-09-30	$2.93M	12.32%
2019-06-30	$2.61M	5.41%
2019-03-31	$2.47M	8.61%
2018-12-31	$2.28M	25.98%
2018-09-30	$1.81M	9.76%
2018-06-30	$1.65M	1.41%
2018-03-31	$1.62M	-3.34%
2017-12-31	$1.68M	-2.20%
2017-09-30	$1.72M	-13.10%
2017-06-30	$1.98M	-1.55%
2017-03-31	$2.01M	22.75%
2016-12-31	$1.64M	1.16%
2016-09-30	$1.62M	46.42%
2016-06-30	$1.10M	-20.82%
2016-03-31	$1.39M	-7.77%
2015-12-31	$1.51M	21.28%
2015-09-30	$1.25M	50.95%
2015-06-30	$825.74K	-18.28%
2015-03-31	$1.01M	5.27%
2014-12-31	$959.84K	51.58%
2014-09-30	$633.20K	-46.74%
2014-06-30	$1.19M	44.54%
2014-03-31	$822.53K	-30.08%
2013-12-31	$1.18M	26.84%
2013-09-30	$927.46K	64.88%
2013-06-30	$562.49K	-55.51%
2013-03-31	$1.26M	-32.13%
2012-12-31	$1.86M	64.57%
2012-09-30	$1.13M	4.44%
2012-06-30	$1.08M	10.59%
2012-03-31	$980.00K	-15.82%
2011-12-31	$1.16M	0.80%
2011-09-30	$1.15M	59.76%
2011-06-30	$722.89K	-

ClearPoint Neuro generated $8.12M in revenue during Q3 2024, up 3.36% compared to the previous quarter, and up 136.50% compared to the same period a year ago.

ClearPoint Neuro Revenue Breakdown

ClearPoint Neuro Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Capital Equipment and Software - Services	$1.06M	$973.00K	$795.00K	$569.00K	-
Capital Equipment and Software - Systems and Software Products	$2.73M	$860.00K	$1.51M	$864.00K	-
Capital Equipment and Software Revenue	$3.79M	$1.83M	$2.31M	$1.43M	$1.49M
Biologics and Drug Delivery - Disposable Products	$5.61M	$2.15M	$3.69M	$3.35M	-
Biologics and Drug Delivery Revenue	$17.31M	$13.60M	$9.12M	$6.79M	$5.04M
Functional Neurosurgery Navigation and Therapy - Services	-	$931.00K	$1.54M	$375.00K	-
Functional Neurosurgery Navigation and Therapy	-	$8.52M	$9.12M	$8.07M	-
Functional Neurosurgery Navigation and Therapy - Disposable Products	-	$7.59M	$7.59M	$7.70M	-
Biologics and Drug Delivery - Services	-	-	-	$3.44M	-

ClearPoint Neuro's latest annual revenue breakdown by segment (product or service), as of Dec 24: Biologics and Drug Delivery Revenue (56.74%), Biologics and Drug Delivery - Disposable Products (18.38%), Capital Equipment and Software Revenue (12.44%), Capital Equipment and Software - Systems and Software Products (8.97%), and Capital Equipment and Software - Services (3.47%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
Biologics And Drug Delivery	$4.43M	$4.31M	$3.49M	$3.37M	$2.68M	$2.25M	$2.41M	$2.15M	$72.50K	$244.95K	-	-	-	-	-	-	-	-	-	-
Capital Equipment And Software - Services	$279.00K	$250.00K	$276.00K	$208.00K	$218.00K	$193.00K	$185.00K	$189.00K	-	-	-	-	-	-	-	-	-	-	-	-
Capital Equipment And Software - Systems and Software Products	$552.00K	$1.16M	$81.00K	$173.00K	$178.00K	$287.00K	$434.00K	$450.00K	-	-	-	-	-	-	-	-	-	-	-	-
Capital Equipment And Software	$831.00K	$1.41M	$357.00K	$381.00K	$396.00K	$480.00K	$619.00K	$639.00K	-	-	-	-	-	-	-	-	-	-	-	-
Biologics And Drug Delivery - Disposable Products	$2.06M	$553.00K	$455.00K	$346.00K	$594.00K	$798.00K	$1.23M	$850.00K	-	-	-	-	-	-	-	-	-	-	-	-
Functional Neurosurgery Navigation and Therapy - Services	-	-	$1.00K	$44.00K	$383.00K	$503.00K	$375.00K	$375.00K	$375.00K	-	-	-	-	-	-	-	-	-	-	-
Functional Neurosurgery Navigation and Therapy	-	$1.93M	$2.04M	$1.92M	$2.20M	$2.36M	$2.42M	$2.17M	$2.24M	$2.14M	-	-	-	-	-	-	-	-	-	-
Functional Neurosurgery Navigation and Therapy - Disposable Products	-	$1.93M	$2.04M	$1.87M	$1.82M	$1.86M	$2.04M	$1.80M	$1.86M	-	-	-	-	-	-	-	-	-	-	-
Biologics And Drug Delivery - Services	-	-	-	-	-	-	$1.45M	$1.18M	$1.30M	-	-	-	-	-	-	-	-	-	-	-
Biologics and Drug Delivery - Disposable Products	-	-	-	-	-	-	-	-	-	$852.00K	-	-	-	-	-	-	-	-	-	-
Biologics and Drug Delivery Revenue	-	-	-	-	-	-	-	-	-	$1.69M	$1.66M	-	-	-	-	-	-	-	-	-
Capital Equipment and Software - Services	-	-	-	-	-	-	-	-	-	$170.00K	-	-	-	-	-	-	-	-	-	-
Capital Equipment and Software - Systems and Software Products	-	-	-	-	-	-	-	-	-	$284.00K	-	-	-	-	-	-	-	-	-	-
Biologics and Drug Delivery - Services	-	-	-	-	-	-	-	-	-	$837.00K	-	-	-	-	-	-	-	-	-	-
Capital Equipment and Software Revenue	-	-	-	-	-	-	-	-	-	$454.00K	$453.00K	-	-	-	-	-	-	-	-	-
Capital Equipment Related Service Revenue	-	-	-	-	-	-	-	-	-	-	$100.00K	$90.00K	-	-	-	-	-	-	-	-
Remaining Performance Obligations Capital Equipment-Related Service Revenue	-	-	-	-	-	-	-	-	-	-	$800.00K	-	$-320.00K	$992.00K	-	-	-	-	-	-
Capital Equipment-Related Service Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$217.00K	$89.00K	$121.00K	-	-	-	-
Capital Equipment and Software Revenue Subtotal	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$204.56K	-	-	-	-	-
Biologics and Drug Delivery Revenue Subtotal	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.47M	-	-	-	-	-
Therapy Revenue Subtotal	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$103.80K	-	-	-	-	-
Product Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.52M	-	-
Service and Other Revenues	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$686.77K	$333.04K	$412.20K
Functional Neurology	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.85M	$1.69M
Capital Equipment	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$184.82K	$241.29K
Capital Equipment and Other	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$210.54K	$243.95K
Biologics and Drug Delivery	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$491.26K	-
Product Revenues	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.59M	$2.19M
Therapy	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$64.09K	$17.83K
Therapy1Member	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$50.00K	-
BiologicsAndDrugDelivery1Member	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$168.25K

ClearPoint Neuro's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Biologics And Drug Delivery (54.33%), Biologics And Drug Delivery - Disposable Products (25.29%), Capital Equipment And Software (10.19%), Capital Equipment And Software - Systems and Software Products (6.77%), and Capital Equipment And Software - Services (3.42%).

ClearPoint Neuro Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
LIVN	LivaNova	$1.25B	$318.11M
INSP	Inspire Medical Systems	$802.80M	$203.19M
INGN	Inogen	$335.70M	$88.83M
TMCI	Treace Medical Concepts	$209.36M	$45.09M
KIDS	OrthoPediatrics	$204.73M	$52.80M
SRDX	Surmodics	$126.08M	$29.92M
OM	Outset Medical	$113.69M	$28.67M
LUNG	Pulmonx	$83.79M	$20.39M
NPCE	NeuroPace	$79.91M	$21.06M
SGHT	Sight Sciences	$79.87M	$20.16M
TELA	TELA Bio	$69.30M	$18.96M
RCEL	AVITA Medical	$50.56M	$21.23M
APYX	Apyx Medical	$48.10M	$16.02M
CLPT	ClearPoint Neuro	$31.39M	$8.12M
CTSO	Cytosorbents	$25.13M	$8.61B

CLPT Revenue FAQ

What is ClearPoint Neuro’s yearly revenue?

ClearPoint Neuro's yearly revenue for 2024 was $31.39M, representing an increase of 31.04% compared to 2023. The company's yearly revenue for 2023 was $23.96M, representing an increase of 16.56% compared to 2022. CLPT's yearly revenue for 2022 was $20.55M, representing an increase of 26.09% compared to 2021.

What is ClearPoint Neuro’s quarterly revenue?

ClearPoint Neuro's quarterly revenue for Q3 2024 was $8.12M, a 3.36% increase from the previous quarter (Q2 2024), and a 40.96% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $7.86M, a 2.87% increase from the previous quarter (Q1 2024), and a 32.07% increase year-over-year (Q2 2023). CLPT's quarterly revenue for Q1 2024 was $7.64M, a 12.17% increase from the previous quarter (Q4 2023), and a 40.60% increase year-over-year (Q1 2023).

What is ClearPoint Neuro’s revenue growth rate?

ClearPoint Neuro's revenue growth rate for the last 3 years (2022-2024) was 52.74%, and for the last 5 years (2020-2024) was 144.68%.

What are ClearPoint Neuro’s revenue streams?

ClearPoint Neuro's revenue streams in c 24 are Capital Equipment and Software - Services, Capital Equipment and Software - Systems and Software Products, Capital Equipment and Software Revenue, Biologics and Drug Delivery - Disposable Products, and Biologics and Drug Delivery Revenue. Capital Equipment and Software - Services generated $1.06M in revenue, accounting 3.47% of the company's total revenue, up 8.94% year-over-year. Capital Equipment and Software - Systems and Software Products generated $2.74M in revenue, accounting 8.97% of the company's total revenue, up 218.02% year-over-year. Capital Equipment and Software Revenue generated $3.8M in revenue, accounting 12.44% of the company's total revenue, up 107.04% year-over-year. Biologics and Drug Delivery - Disposable Products generated $5.61M in revenue, accounting 18.38% of the company's total revenue, up 160.26% year-over-year. Biologics and Drug Delivery Revenue generated $17.31M in revenue, accounting 56.74% of the company's total revenue, up 27.26% year-over-year.

What is ClearPoint Neuro’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of ClearPoint Neuro was Biologics and Drug Delivery Revenue. This segment made a revenue of $17.31M, representing 56.74% of the company's total revenue.